Alternative splicing and mutation status of CHEK2 in stage III breast cancer. (Q48173616)

9 February 2018

title

Alternative splicing and mutation status of CHEK2 in stage III breast cancer. (English)

1 reference

9 February 2018

alternative mRNA splicing, via spliceosome

main subject

1 reference

6

1 reference

9 February 2018

Jiří Bártek

8

object named as

Jiri Bartek

1 reference

9 February 2018

9

Per Eystein Lønning

1 reference

PubMed ID

15361853

9 February 2018

Anne-Lise Børresen-Dale

5

object named as

Anne-Lise Børresen-Dale

1 reference

9 February 2018

4

Jirina Bartkova

1 reference

9 February 2018

3

Stephanie Geisler

1 reference

9 February 2018

Johan Richard Lillehaug

7

object named as

Johan Richard Lillehaug

1 reference

9 February 2018

author name string

Vidar Staalesen

1

1 reference

9 February 2018

Jacob Falck

2

1 reference

9 February 2018

language of work or name

English

0 references

publication date

1 November 2004

1 reference

9 February 2018

published in

Oncogene

1 reference

9 February 2018

volume

23

1 reference

9 February 2018

page(s)

8535-8544

1 reference

9 February 2018

issue

52

1 reference

9 February 2018

https://scigraph.springernature.com/pub.10.1038/sj.onc.1207928

exact match

0 references

cites work

Phosphorylation of threonine 68 promotes oligomerization and autophosphorylation of the Chk2 protein kinase via the forkhead-associated domain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207928

Mutation analysis of the CHK2 gene in families with hereditary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207928

CHK2 kinase--a busy messenger.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207928

Mutations in CHEK2 associated with prostate cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207928

The hCds1 (Chk2)-FHA domain is essential for a chain of phosphorylation events on hCds1 that is induced by ionizing radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207928

The CHEK2 1100delC mutation identifies families with a hereditary breast and colorectal cancer phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207928

p73 is over-expressed in vulval cancer principally as the Delta 2 isoform

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207928

Analysis of CHK2 in vulval neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207928

CHEK2 variants associate with hereditary prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207928

A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207928

Targeting the checkpoint kinases: chemosensitization versus chemoprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207928

Screening hCHK2 for Mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207928

Chk1 and Chk2 kinases in checkpoint control and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207928

7 January 2021

Chk2 tumour suppressor protein in human spermatogenesis and testicular germ-cell tumours

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207928

7 January 2021

Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207928

7 January 2021

Functional impact of concomitant versus alternative defects in the Chk2-p53 tumour suppressor pathway.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207928

7 January 2021

The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207928

7 January 2021

DNA damage-induced activation of p53 by the checkpoint kinase Chk2

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207928

7 January 2021

hCds1-mediated phosphorylation of BRCA1 regulates the DNA damage response

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207928

7 January 2021

Linkage of ATM to cell cycle regulation by the Chk2 protein kinase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207928

7 January 2021

CHEK2 variants in susceptibility to breast cancer and evidence of retention of the wild type allele in tumours

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207928

7 January 2021

A robust method for detecting CHK2/RAD53 mutations in genomic DNA.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207928

7 January 2021

Concomitant inactivation of p53 and Chk2 in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207928

7 January 2021

Role of human Cds1 (Chk2) kinase in DNA damage checkpoint and its regulation by p53

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207928

7 January 2021

Polymorphic hCHK2/hCds1 codon 84 allele and risk of squamous cell carcinoma of the head and neck--a case-control analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207928

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1207928

1 reference

9 February 2018

PubMed ID

15361853

1 reference

9 February 2018